Digoxin Renal Dose Adjustment
In patients with renal impairment, digoxin maintenance doses must be reduced based on creatinine clearance, with doses ranging from 0.0625 mg every other day to 0.25 mg daily depending on renal function, and elderly patients (>70 years) should start at 0.125 mg daily or lower regardless of calculated creatinine clearance.
Dosing Algorithm Based on Renal Function
Standard Maintenance Dosing for Adults with Normal Renal Function
- 0.25 mg daily for patients <70 years with normal renal function 1, 2, 3
- 0.125 mg daily for patients >70 years OR with impaired renal function 1, 2, 3
- 0.0625 mg daily for patients with marked renal impairment 1, 3
Specific Dose Adjustments by Creatinine Clearance
The FDA label provides a detailed dosing table based on lean body weight and creatinine clearance 3. For a standard 70 kg patient:
- CrCl ≥60 mL/min: 187.5-250 mcg (0.1875-0.25 mg) daily
- CrCl 40-60 mL/min: 187.5-250 mcg (0.1875-0.25 mg) daily
- CrCl 30-40 mL/min: 125-187.5 mcg (0.125-0.1875 mg) daily
- CrCl 20-30 mL/min: 125-187.5 mcg (0.125-0.1875 mg) daily
- CrCl 10-20 mL/min: 125 mcg (0.125 mg) daily
- CrCl <10 mL/min: 62.5-125 mcg (0.0625-0.125 mg) daily 3
Critical Considerations for Renal Dosing
Why Renal Function Matters
Digoxin is primarily eliminated renally, and both clearance AND volume of distribution decrease with declining kidney function 4. This dual effect means that patients with renal impairment are at substantially higher risk for toxicity even with standard doses 5.
Which Equation to Use for CrCl Estimation
Use the Cockcroft-Gault equation corrected to 70 kg body weight for digoxin dose adjustment 3. The formula provided in the FDA label is:
- For men: CrCl = (140 - Age) / Serum Creatinine
- For women: Multiply the above result by 0.85 3
Recent research suggests that deindexed eGFR by MDRD may have the highest correlation with digoxin levels 6, but the established guidelines and FDA label consistently reference Cockcroft-Gault 3.
Special Populations Requiring Lower Doses
Elderly patients (>70 years) require dose reduction even with "normal" serum creatinine because:
- Age-related decline in renal function may not be reflected in serum creatinine 2, 7
- Reduced lean body mass decreases volume of distribution 2, 7
- Prolonged half-life (3.5-6 days vs. normal 1.5-2 days) 8
Patients with CrCl <60 mL/min are at significantly increased risk of toxic concentrations and should receive reduced loading doses (6-10 mcg/kg instead of 8-12 mcg/kg) 5.
Target Serum Concentrations
Target digoxin levels: 0.5-0.9 ng/mL (lower than historically recommended) 9, 2, 10
The ESC guidelines specify therapeutic range of 0.6-1.2 ng/mL 9, while ACC/AHA guidelines emphasize 0.5-0.9 ng/mL based on retrospective analyses showing increased mortality at higher levels 2, 7. Levels >1.2 ng/mL are associated with increased mortality risk 11, 10.
Monitoring and Timing
- Check digoxin levels at least 6-8 hours after the last dose, preferably just before the next dose 3
- Steady-state is achieved in 5 half-lives: 7-11 days in normal renal function, up to 22 days with severe renal impairment 3
- Monitor potassium, magnesium, and renal function regularly, as hypokalemia and hypomagnesemia increase toxicity risk even at therapeutic digoxin levels 1, 2, 7
Drug Interactions Requiring Dose Reduction
Reduce digoxin dose by approximately 50% when initiating:
Common Pitfalls
- Using actual body weight instead of lean body weight - digoxin does not distribute into adipose tissue 3
- Failing to reduce doses in elderly patients with "normal" creatinine - age-related GFR decline may be masked 2, 8
- Not accounting for the prolonged time to steady-state in renal impairment - may take 3+ weeks 3
- Ignoring electrolyte abnormalities - toxicity can occur at "therapeutic" levels with hypokalemia 1, 7